Skip to main
PHAS

PHAS Earnings Dates & Reports

PHAS Most Recent Earnings

Report Date
Period EndingQ2 2022
Est. EPS-$0.33
Actual EPS-$0.34
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

PHAS Earnings per Share (EPS) History

Signup for full access
Browse free

PHAS Latest Earnings

The value each PHAS share was expected to gain vs. the value each share gained.

PHAS reported its most recent earnings on for Q2 2022, posting earnings per share (EPS) of -$0.34. This exceeded analysts' expectations of -$0.33 by 3.03%, marking a Miss.

For comparison, PhaseBio Pharmaceuticals Inc reported EPS of -$0.60 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.

PHAS Earnings History

Earnings
Est. EPSActual EPSSurprise
Q2 2022
-$0.33-$0.34+3.03%
DeckReportListen
Q1 2022
-$0.66-$0.23-65.15%
DeckReportListen
Q4 2021
-$0.59-$0.90+52.54%
DeckReportListen
Q3 2021
-$0.61-$0.66+8.20%
DeckReportListen
Q2 2021
-$0.48-$0.60+25.00%
DeckReportListen
View all

PHAS Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the PhaseBio Pharmaceuticals Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

PHAS Earnings FAQs

PHAS last reported earnings on Aug 12, 2022 for Q2 2022, posting an EPS of -$0.34, which Miss the estimate of -$0.33 by 3.03%.

For Q2 2022, PHAS reported an EPS of -$0.34, missing analysts' estimate of -$0.33 by 3.03%.

For Q2 2022, PHAS Miss expectations with an actual EPS of -$0.34 vs. an estimated EPS of -$0.33.

Following the last earnings report on Aug 12, 2022, PHAS's stock price moved — from — to —.

The next PHAS earnings call is scheduled for Aug. 12, 2022, where executives will discuss financial results and outlook.

PhaseBio Pharmaceuticals Inc (PHAS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.